Interaction between dextran and human low density lipoproteins (LDL) observed using laser light scattering

Dextran infusions in humans have been linked to reduced low density lipoprotein (LDL) levels in plasma. Prior research has shown that dextran can influence lipid metabolism, but the specific mechanisms remain unclear. Established knowledge indicates that dextran is a non-sulphated polysaccharide with known effects on plasma lipids. However, the interaction between dextran and LDL particles has not been fully characterized. This gap motivated researchers to investigate the in vitro behavior of dextran and LDL. No prior work had resolved the structural changes in LDL when exposed to dextran. The need to understand these interactions stems from their potential relevance to lipid metabolism in vivo. This paper's contribution lies in providing direct evidence of dextran-LDL associations.

The aim of this study was to examine the interaction between dextran and human LDL in vitro. The specific problem addressed is the lack of detailed understanding of how dextran affects LDL structure and aggregation. The motivation stems from the observed in vivo effects of dextran on lipid metabolism. Researchers sought to determine if dextran can induce LDL aggregation. They also aimed to measure the hydrodynamic radius of LDL before and after dextran exposure. The study focused on dextran of molecular weights 40,000 and 70,000 g/mol. The goal was to observe structural changes in LDL using light scattering techniques. This approach allows for precise measurements of particle size and association.

The study used static and dynamic light scattering to analyze dextran-LDL interactions. Human LDL samples were prepared with an apoB concentration of 0.75 g/l. Dextran solutions of molecular weights 40,000 and 70,000 g/mol were used in the experiments. The experiments were conducted at a temperature of 25°C to ensure consistency. Dextran concentrations of 10 and 50 g/l were tested after mixing with LDL. The hydrodynamic radius of LDL was measured before dextran addition. The formation of LDL associates was observed through changes in light scattering patterns. These methods allowed for the detection of structural changes in LDL particles.

The hydrodynamic radius of native LDL was measured at 12.9 nm. After dextran addition, LDL associates formed with a mean radius of approximately 200 nm. The formation of these larger structures was observed at both dextran concentrations tested. The results suggest that dextran induces aggregation of LDL particles in vitro. The effect was consistent across both molecular weights of dextran used. The observed changes in particle size indicate a significant interaction between dextran and LDL. These findings provide direct evidence of dextran-LDL associations. The results support the hypothesis that dextran can alter LDL structure in solution.

The findings show that non-sulphated polysaccharides like dextran can interact with LDL. The formation of LDL associates in vitro was detected through light scattering measurements. These results suggest a possible mechanism for the in vivo effects of dextran on lipid metabolism. The study does not propose new drug targets or future directions. The authors state that the dextran-dependent formation of LDL associates could explain the observed in vivo effects. The conclusions are limited to the direct evidence presented in the experiments. No essential or central role is assigned to dextran in lipid metabolism. The implications are based solely on the observed structural changes in LDL.